Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2385-2394

  Kim, Jeong Hyun ^a   Park, Byung Lae ^b   Pasaje, Charisse Flerida A ^a   Bae, Joon Seol ^a   Park, Jong Sook ^a,c   Park, Sung Woo ^c   Uh, Soo Taek ^c   Choi, Jae Sung ^c   Kim, Yong Hoon ^a   Kim, Mi Kyeong ^d   Choi, Inseon S ^e   Cho, Sang Heon ^f   Choi, Byoung Whui ^g   Park, Choon Sik ^c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Chungbuk National University   (South Korea)

^e Chonnam National University   (South Korea)

^f Seoul National University   (South Korea)

^g Chung Ang University   (South Korea)

Author keywords

Aspirin exacerbated respiratory disease (AERD); FANCC; Haplotype; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; FANCONI ANEMIA GROUP C PROTEIN;

ADOLESCENT; ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; COMPUTER ANALYSIS; CONTROLLED STUDY; FANCC GENE; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PROVOCATION TEST; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; ALTERNATIVE SPLICING; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHYSICAL CHROMOSOME MAPPING; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA;

MUS;

EID: 84863840545     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0989-6     Document Type: Article

References (33)

1. Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28(4):717-722
2. Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111(5):913-921
3. Babu KS, Salvi SS (2000) Aspirin and asthma. Chest 118(5): 1470-1476
4. Bel EH (2004) Clinical phenotypes of asthma. Curr Opin Pulm Med 10(1):44-50
5. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH (2002) Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 347(19): 1493-1499
6. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, Park CS et al (2004) Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114(4):337-344
7. Sanak M, Simon HU, Szczeklik A (1997) Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350(9091):1599-1600
8. Kim SH, Oh JM, Kim YS, Palmer LJ, Suh CH, Nahm DH et al (2006) Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 36(4):433-439
9. Park JS, Chang HS, Park CS, Lee JH, Lee YM, Choi JH et al (2005) Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15(7):483-492
10. Koppelman GH, Meyers DA, Howard TD, Zheng SL, Hawkins GA, Ampleford EJ et al (2009) Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 180(10):929-935
11. Camateros P, Marino R, Fortin A, Martin JG, Skamene E, Sladek R et al (2010) Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice. Mamm Genome 21(1-2):28-38
12. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M (1993) A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 4(2):202-205
13. Nowzari H, Jorgensen MG, Ta TT, Contreras A, Slots J (2001) Aggressive periodontitis associated with Fanconi's anemia. A case report. J Periodontol 72(11):1601-1606
14. Sejas DP, Rani R, Qiu Y, Zhang X, Fagerlie SR, Nakano H et al (2007) Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice. J Immunol 178(8): 5277-5287
15. Makowska JS, Grzegorczyk J, Bienkiewicz B, Wozniak M, Kowalski ML (2008) Systemic responses after bronchial aspirin challenge in sensitive patients with asthma. J Allergy Clin Immunol 121(2):348-354
16. Cormican LJ, Farooque S, Altmann DR, Lee TH (2005) Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy 35(6):717-722
17. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G et al (2007) EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62(10):1111-1118
18. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265
19. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978-989
20. Coulombe-Huntington J, Lam KC, Dias C, Majewski J (2009) Fine-scale variation and genetic determinants of alternative splicing across individuals. PLoS Genet 5(12):e1000766
21. Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A et al (1999) Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160(1):291-296
22. Sekigawa T, Tajima A, Hasegawa T, Hasegawa Y, Inoue H, Sano Y et al (2009) Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirinintolerant asthma. Clin Exp Allergy 39(7):972-981
23. Spahn JD, Cherniack R, Paull K, Gelfand EW (2004) Is forced expiratory volume in one second the best measure of severity in childhood asthma? Am J Respir Crit Care Med 169(7):784-786
24. Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW et al (2001) FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 107(1):61-67
25. Zhang X, Li J, Sejas DP, Pang Q (2005) Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood 106(1):75-85
26. Kim SH, Ye YM, Lee SK, Park HS (2006) Genetic mechanism of aspirin-induced urticaria/angioedema. Curr Opin Allergy Clin Immunol 6(4):266-270
27. Que C, Cullinan P, Geddes D (2006) Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 61(2):155-157
28. Judge EP, Dodd JD, Masterson JB, Gallagher CG (2006) Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 130(5):1424-1432
29. Konstan MW, Schluchter MD, Xue W, Davis PB (2007) Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med 176(11):1084-1089
30. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, Hirota T et al (2009) Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirininduced asthma. J Allergy Clin Immunol 124(4):779-785 e776
31. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M (1996) Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 26(7):807-814
32. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM et al (1997) Allergen-induced increases in IL-5 receptor alphasubunit expression on bone marrow-derived CD34 ? cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 100(10): 2466-2475
33. Dorman SC, Sehmi R, Gauvreau GM, Watson RM, Foley R, Jones GL et al (2004) Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169(5):565-572